Cibc Private Wealth Group, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,050 shares of MDGL stock, worth $365,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,050
Previous 3,100
66.13%
Holding current value
$365,767
Previous $657,000
50.84%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MDGL
# of Institutions
336Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$769 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$711 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$707 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$695 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$688 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.96B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...